Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease

被引：0
|
作者：
Morales, Ahmed
Salguti, Sandhya
Miao, Chuan L.
Lewis, James D.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A211 / A211
页数：1
相关论文
共 50 条
  • [21] Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine
    Jharap, B.
    de Boer, N. K. H.
    Vos, R. M.
    Smid, K.
    Zwiers, A.
    Peters, G. J.
    Mulder, C. J. J.
    Wilhelm, A. J.
    van Bodegraven, A. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (04) : 722 - 731
  • [22] ELECTRONIC-STRUCTURES AND SPECTRA OF 6-MERCAPTOPURINE AND 6-THIOGUANINE
    SANTHOSH, C
    MISHRA, PC
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 1993, 49 (07): : 985 - 993
  • [23] Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease
    Derijks, LJJ
    Gilissen, LPL
    Engels, LGJB
    Bos, LP
    Bus, PJ
    Lohman, JJHM
    Hooymans, PM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 466 - 466
  • [24] Maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients
    De Boer, NK
    Derijks, LJ
    Gilissen, LP
    Hommes, DW
    Engels, LG
    de Boer, S
    den Hartog, B
    Hooymans, PM
    Makelburg, AB
    Naber, AH
    Westerveld, DB
    Mulder, CJ
    de Jong, DJ
    GASTROENTEROLOGY, 2005, 128 (04) : A199 - A199
  • [25] Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide
    Inamochi, H
    Higashigawa, M
    Shimono, Y
    Nagata, T
    Cao, DC
    Mao, XY
    M'soka, T
    Hori, H
    Kawasaki, H
    Sakurai, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1999, 18 (03) : 417 - 424
  • [26] Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
    Osterman, MT
    Kundu, R
    Lichtenstein, GR
    Lewis, JD
    GASTROENTEROLOGY, 2006, 130 (04) : 1047 - 1053
  • [27] 6-mercaptopurine metabolite levels in children with inflammatory bowel disease
    Gupta, P
    Gokhale, R
    Kirschner, BS
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 33 (04): : 450 - 454
  • [28] The Efficacy of Low Dose Azathioprine/6-mercaptopurine in Patients with Inflammatory Bowel Disease
    Kim, Dong Uk
    Kim, Young-Ho
    Kim, Beom Jin
    Chang, Dong Kyung
    Son, Hee Jung
    Rhee, Poong-Lyul
    Kim, Jae J.
    Rhee, Jong Chul
    HEPATO-GASTROENTEROLOGY, 2009, 56 (94-95) : 1395 - 1402
  • [29] Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
    Yarur, Andres J.
    Kubiliun, Maddie J.
    Czul, Frank
    Sussman, Daniel A.
    Quintero, Maria A.
    Jain, Anjali
    Drake, Katherine A.
    Hauenstein, Scott I.
    Lockton, Steven
    Deshpande, Amar R.
    Barkin, Jamie S.
    Singh, Sharat
    Abreu, Maria T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) : 1118 - +
  • [30] MECHANISMS OF ACTION OF 6-THIOGUANINE, 6-MERCAPTOPURINE, AND 8-AZAGUANINE
    NELSON, JA
    CARPENTER, JW
    ROSE, LM
    ADAMSON, DJ
    CANCER RESEARCH, 1975, 35 (10) : 2872 - 2878
12345